Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adenocarcinoma × ipatasertib × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 2 Gastrointestinal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Adenocarcinoma 1

Interventions

Oxaliplatin 28 Fluorouracil 26 Gemcitabine 25 Capecitabine 21 Leucovorin 18 pembrolizumab 15 130-nm albumin-bound paclitaxel 12 Irinotecan 11 Cisplatin 10 Bevacizumab 10 Albumin-Bound Paclitaxel 10 Paclitaxel 9 Radiotherapy 8 Ramucirumab 7 Nivolumab 7 Docetaxel 7 trastuzumab deruxtecan 6 Cyclophosphamide 6 durvalumab 4 Taxes 4 Metformin 4 zolbetuximab 3 folfirinox 3 cemiplimab 3 XELOX 3 Trastuzumab 3 Surgical Procedures, Operative 3 Sorafenib 3 Ipilimumab 3 Drug Therapy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04739202 2021-03-29

IMMUNOGAST

Hospices Civils de Lyon

Phase 2 Unknown

Gastrointestinal

Adenocarcinoma, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡